Insights

Presbyopia Market Potential LENZ Therapeutics targets a sizable market, with presbyopia affecting almost two billion people globally and over 120 million in the US, presenting a significant sales opportunity for its innovative ophthalmic products.

Venture Capital Backing Backed by multiple blue-chip venture capital investors, LENZ Therapeutics is well-positioned to leverage investor support and financial backing to drive sales growth and product development.

Competitive Landscape Although LENZ Therapeutics competes with larger pharmaceutical companies like Roche, Boehringer Ingelheim, and Johnson & Johnson, its focus on innovative ophthalmic products tailored for presbyopia provides a unique selling proposition in the market.

Revenue and Funding With revenue in the range of $0 - 10M and recent funding of $30M, LENZ Therapeutics has the financial resources to invest in sales and marketing initiatives to accelerate market penetration and revenue growth.

Tech-Driven Approach Utilizing a tech stack including Google Analytics, Shopify, and other tools, LENZ Therapeutics demonstrates a technology-driven approach that can enhance sales strategies, customer engagement, and operational efficiency.

LENZ Therapeutics Tech Stack

LENZ Therapeutics uses 8 technology products and services including Google Analytics, Shopify, Revslider, and more. Explore LENZ Therapeutics's tech stack below.

  • Google Analytics
    Analytics
  • Shopify
    E-commerce
  • Revslider
    Miscellaneous
  • wpBakery
    Page Builders
  • Lua
    Programming Languages
  • PHP
    Programming Languages
  • GoDaddy CoBlocks
    Web Platform Extensions
  • OpenResty
    Web Servers

Media & News

LENZ Therapeutics's Email Address Formats

LENZ Therapeutics uses at least 1 format(s):
LENZ Therapeutics Email FormatsExamplePercentage
First@lenz-tx.comJohn@lenz-tx.com
46%
First.Last@lenz-tx.comJohn.Doe@lenz-tx.com
4%
First@lenz-tx.comJohn@lenz-tx.com
46%
First.Last@lenz-tx.comJohn.Doe@lenz-tx.com
4%

Frequently Asked Questions

Where is LENZ Therapeutics's headquarters located?

Minus sign iconPlus sign icon
LENZ Therapeutics's main headquarters is located at 125 S Highway 101 San Diego, California 92075 US. The company has employees across 2 continents, including North AmericaAsia.

What is LENZ Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
LENZ Therapeutics's official website is lenz-tx.com and has social profiles on LinkedIn.

How much revenue does LENZ Therapeutics generate?

Minus sign iconPlus sign icon
As of September 2024, LENZ Therapeutics's annual revenue reached $1.8M.

What is LENZ Therapeutics's NAICS code?

Minus sign iconPlus sign icon
LENZ Therapeutics's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does LENZ Therapeutics have currently?

Minus sign iconPlus sign icon
As of September 2024, LENZ Therapeutics has approximately 34 employees across 2 continents, including North AmericaAsia. Key team members include Chief Financial Officer: D. C.Chief Commercial Officer (cco): S. O.Chief Operating Officer: K. S.. Explore LENZ Therapeutics's employee directory with LeadIQ.

What industry does LENZ Therapeutics belong to?

Minus sign iconPlus sign icon
LENZ Therapeutics operates in the Pharmaceutical Manufacturing industry.

What technology does LENZ Therapeutics use?

Minus sign iconPlus sign icon
LENZ Therapeutics's tech stack includes Google AnalyticsShopifyRevsliderwpBakeryLuaPHPGoDaddy CoBlocksOpenResty.

What is LENZ Therapeutics's email format?

Minus sign iconPlus sign icon
LENZ Therapeutics's email format typically follows the pattern of . Find more LENZ Therapeutics email formats with LeadIQ.

How much funding has LENZ Therapeutics raised to date?

Minus sign iconPlus sign icon
As of September 2024, LENZ Therapeutics has raised $30M in funding. The last funding round occurred on Jul 15, 2024 for $30M.
LENZ Therapeutics

LENZ Therapeutics

Pharmaceutical ManufacturingCalifornia, United States11-50 Employees

LENZ Therapeutics is a late-stage clinical company developing innovative ophthalmic pharmaceutical products that improve vision. Our lead program is an aceclidine based eye drop designed to restore the loss of near vision associated with presbyopia. Presbyopia impacts almost two billion people globally and more than 120 million people in the US. LENZ Therapeutics is headquartered in San Diego, California, and is backed by multiple blue-chip venture capital investors.

Section iconCompany Overview

Headquarters
125 S Highway 101 San Diego, California 92075 US
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $30M

    LENZ Therapeutics has raised a total of $30M of funding over 5 rounds. Their latest funding round was raised on Jul 15, 2024 in the amount of $30M.

  • $10M

    LENZ Therapeutics's revenue is in the range of $10M

Section iconFunding & Financials

  • $30M

    LENZ Therapeutics has raised a total of $30M of funding over 5 rounds. Their latest funding round was raised on Jul 15, 2024 in the amount of $30M.

  • $10M

    LENZ Therapeutics's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.